The Influence of P170-glycoprotein modulators on the efficacy and the distribution of vincristine as well as on MDR1 expression in BRO/mdr1.1 human melanoma xenografts-Reference-Cited by-同舟云学术

The Influence of P170-glycoprotein modulators on the efficacy and the distribution of vincristine as well as on MDR1 expression in BRO/mdr1.1 human melanoma xenografts

Published:1999-05 Issue:5 Volume:35 Page:840-849
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Boven E,Jansen W.J.M,Hulscher T.M,Beijnen J.H,van Tellingen O

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference34 articles.

1. Biochemistry of multidrug resistance mediated by the multidrug transporter;Gottesman;Annu. Rev. Biochem.,1993

2. P-glycoprotein and resistance to anticancer drugs;Ling;Cancer,1992

3. The role of the MDR1 (P-glycoprotein) gene in multidrug resistance in vitro and in vivo;Roninson;Biochem. Pharmacol.,1992

4. Cure of mice bearing P388 leukemia by vincristine in combination with a calcium channel blocker;Tsuruo;Cancer Treat. Rep.,1985

5. In vivo circumvention of vincristine resistance in mice with P388 leukemia using a novel compound, AHC-52;Shinoda;Cancer Res.,1989

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improved brain delivery of vincristine using dextran sulfate complex solid lipid nanoparticles: Optimization andin vivoevaluation;Journal of Biomedical Materials Research Part A;2013-08-06

2. Three Decades of P-gp Inhibitors: Skimming Through Several Generations and Scaffolds;Current Medicinal Chemistry;2012-03-01

3. P-glycoprotein and Mrp1 collectively protect the bone marrow from vincristine-induced toxicity in vivo;British Journal of Cancer;2003-10-28